Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aqueduct of Sylvius, stenosis
aqueductal stenosis
blindness
cataracts
cataracts, congenital
cerebellar hypoplasia
contractures, joint
cornea, opacity of
encephalocele
genetic neurologic disorders
hydrocephalus
hydrocephalus, congenital
hypotonia
joint hypermobility
lissencephaly
malformation, CNS, congenital
micropthalmia
MRI
MRI, abnormal
muscle weakness
muscular dystrophy
muscular dystrophy, central nervous system abnormality
muscular dystrophy, classification
muscular dystrophy, congenital
muscular dystrophy, congenital, Fukuyama type
muscular dystrophy, congenital, Ullrich
neuropathology, brain
psychomotor retardation
retinal detachment
retinal dysplasia
review article
Walker-Warburg syndrome
white matter disease
Showing articles 850 to 900 of 1936 << Previous Next >>

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001

Relative Pupil-Sparing Third Nerve Palsy:Etiology and Clinical Variables Predictive of a Mass
Neurol 56:797-798, Jacobson,D.M., 2001

Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001

Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001

Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001

Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001

Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Stroke in a Healthy 46-Year-Old Man
JAMA 285:2757-2762, Wityk,R.J., 2001

Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001

Thrombolysis of Extracranial and Intracranial Arteries After IV Abciximab
Neurol 56:1582-1584, Houdart,E.,et al, 2001

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

A Language Barrier, Abdominal Pain, and Double Vision
Lancet 357:2022, Basnyat,B.,et al, 2001

Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey
Lancet 358:261-264,254, Mostashari,F.,et al, 2001

CT Angiography in the Rapid Triage of Patients with Hyperacute Stroke to Intraarterial Thrombolysis: Accuracy in the Detection of Large Vessel Thrombus
J Comput Assist Tomogr 25:520-528, Lev,M.H.,et al, 2001

Cooling for Acute Ischemic Brain Damage (COOL AID)
Stroke 32:1847-1854, Krieger,D.W.,et al, 2001

Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001

Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001

New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies
Neurol 57:S48-S52, Warach,S., 2001

Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001

Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001

Early Carotid Endarterectomy for Critical Carotid Artery Stenosis After Thrombolysis Therapy in Acute Ischemic Stroke in the Middle Cerebral Artery
Stroke 32:2075-2080, McPherson,C.M.,et al, 2001

Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated with Intra-Arterial thrombolysis,Prediction of Final Infarct Volume and Clinical Outcome
Stroke 32:2021-2028, Lev,M.H.,et al, 2001

Extracranial Carotid Stenosis
NEJM 345:1113-1118, Sacco,R., 2001

Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis
Stroke 32:2310-2317, Wassay,M.,et al, 2001

Precipitating Factors in Pituitary Apoplexy
JNNP 71:542-545, Biousse,V.,et al, 2001

Graduating Neurology Residents' Experience with IV tPA for Acute Stroke
Neurol 57:1729-1730,1532, Cucchiara,B.L. &Kasner,S.E., 2001

Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001

CT-Based Assessment of Acute Stroke
Stroke 32:2543-2549, Kilpatrick,M.M.,et al, 2001

Time Course of Tissue Plasminogen Activator-Induced Recanalization in Acute Cardioembolic Stroke
Stroke 32:2821-2827, Molina,C.A.,et al, 2001

Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
JAMA 286:2830-2838, Patel,S.C.,et al, 2001

Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Arch Neurol 58:2009-2013, Grotta,J.C.,et al, 2001

Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001

Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001

Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001

Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001

Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001

Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans
JAMA 286:2437-2440, Becher,M.W.,et al, 2001

Localization of Claude's Syndrome
Neurol 57:2304-2307, Seo,S.W.,et al, 2001

Neuro-Ophthalmic Manifestations of Sarcoidosis. Clincal Spectrum, Evaluation and Management
J Neuroophthalmol 21:132-137, Frohman,L.P,et al, 2001

Isolated Third Nerve Palsy Due to Sarcoidosis
Can J Ophthalmol 36:416-419, Ueyama,H.,et al, 2001

The Tolosa-Hunt Syndrome
JNNP 71:577-582, Kline,L.B. & Hoyt, W.F., 2001

Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000

Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000

Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000



Showing articles 850 to 900 of 1936 << Previous Next >>